Gates G A
Virginia Merrill Bloedel Hearing Research Center, University of Washington, Seattle, 98195-7923, USA.
Otolaryngol Head Neck Surg. 1996 Apr;114(4):525-30. doi: 10.1016/S0194-59989670243-7.
The costs of treatment of children with otitis media with effusion comprise a substantial part of the total health care expenditure. However, there is little information about the value of therapy expressed in cost-effectiveness terms, and disagreement still exists about optimal therapy. This article considers the elements of cost-effectiveness analysis as they pertain to treatment of young children with otitis media with effusion and develops a first approximation model using data from several sources. The assumptions on which this model is based need to be validated by additional research. Otitis media with effusion treatment costs are high because of the large, and apparently increasing, number of symptomatic cases. Medical therapy, which is the primary treatment modality, consumes two thirds of the expenditures for otitis media with effusion. Surgical therapy is a cost-effective treatment for children in whom medical therapy for otitis media with effusion fails. Medical and surgical therapy are complementary, and each should be included in the analysis of cost-effectiveness.
分泌性中耳炎患儿的治疗费用在医疗保健总支出中占相当大的比例。然而，关于以成本效益来衡量治疗价值的信息很少，并且对于最佳治疗方法仍存在分歧。本文探讨了成本效益分析中与幼儿分泌性中耳炎治疗相关的要素，并利用来自多个来源的数据开发了一个初步模型。该模型所基于的假设需要通过进一步研究来验证。由于有症状病例数量众多且明显呈上升趋势，分泌性中耳炎的治疗成本很高。作为主要治疗方式的药物治疗占分泌性中耳炎支出的三分之二。对于分泌性中耳炎药物治疗失败的儿童，手术治疗是一种具有成本效益的治疗方法。药物治疗和手术治疗是相辅相成的，在成本效益分析中都应予以考虑。
